Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07255001 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Using Strength Tests to Better Understand How Pancreatic Cancer Affects Muscle Mass and Quality of Life

Study acronym: PanFit
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Recruitment opened Start date changed from estimate of Dec 2025 to Aug 13, 2026 · Eligibility criteria expanded, about 11 words · Secondary endpoints: details revised at 199 of 202 entries · 2 more Show 5 more changesShow less
    • Start date changed from estimate of Dec 2025 to Aug 13, 2026
    • Eligibility criteria expanded, about 11 words
    • Secondary endpoints: details revised at 199 of 202 entries
    • Site details revised
    • Publications: details revised at 35 of 35 entries
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The goal of this clinical trial is to measure hand grip strength in adults with pancreatic ductal adenocarcinoma (PDAC). The main questions it aims to answer are: * Is it feasible to measure hand grip strength as part of a clinic visit? * Are changes in hand grip strength related to changes in body composition? * Is hand grip strength related to a person's well-being? * Is hand grip strength related to how a tumour responds to treatment? Participants will squeeze a device with their hand to measure their hand grip strength and complete questionnaires about their well-being when they are seen in clinic for their regular medical care for PDAC.
Trial Details
NCT Number NCT07255001
Lead Sponsor British Columbia Cancer Agency
Conditions Pancreatic Ductal Adenocarcinoma (PDAC), Hand Grip Strength
Enrollment 50 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov